Laurel Wealth Advisors (North Carolina)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26M | Buy |
224,661
+221,406
| +6,802% | +$3.21M | 0.05% | 159 |
|
|
2025
Q1 | $226K | Hold |
3,255
| – | – | 0.04% | 167 |
|
|
2024
Q4 | $280K | Buy |
3,255
+1
| +0% | +$86 | 0.04% | 152 |
|
|
2024
Q3 | $387K | Buy |
3,254
+44
| +1% | +$5.24K | 0.06% | 132 |
|
|
2024
Q2 | $458K | Hold |
3,210
| – | – | 0.08% | 127 |
|
|
2024
Q1 | $412K | Hold |
3,210
| – | – | 0.07% | 131 |
|
|
2023
Q4 | $332K | Hold |
3,210
| – | – | 0.06% | 136 |
|
|
2023
Q3 | $292K | Hold |
3,210
| – | – | 0.06% | 139 |
|
|
2023
Q2 | $260K | Hold |
3,210
| – | – | 0.05% | 149 |
|
|
2023
Q1 | $255K | Hold |
3,210
| – | – | 0.05% | 151 |
|
|
2022
Q4 | $217K | Hold |
3,210
| – | – | 0.05% | 154 |
|
|
2022
Q3 | $160K | Hold |
3,210
| – | – | 0.04% | 173 |
|
|
2022
Q2 | $179K | Hold |
3,210
| – | – | 0.04% | 164 |
|
|
2022
Q1 | $178K | Hold |
3,210
| – | – | 0.04% | 176 |
|
|
2021
Q4 | $180K | Hold |
3,210
| – | – | 0.04% | 173 |
|
|
2021
Q3 | $154K | Hold |
3,210
| – | – | 0.03% | 185 |
|
|
2021
Q2 | $134K | Hold |
3,210
| – | – | 0.03% | 193 |
|
|
2021
Q1 | $108K | Hold |
3,210
| – | – | 0.03% | 199 |
|
|
2020
Q4 | $112K | Hold |
3,210
| – | – | 0.03% | 184 |
|
|
2020
Q3 | $111K | Hold |
3,210
| – | – | 0.03% | 174 |
|
|
2020
Q2 | $105K | Hold |
3,210
| – | – | 0.03% | 172 |
|
|
2020
Q1 | $97K | Hold |
3,210
| – | – | 0.04% | 166 |
|
|
2019
Q4 | $93K | Sell |
3,210
-1,800
| -36% | -$52.2K | 0.03% | 188 |
|
|
2019
Q3 | $130K | Hold |
5,010
| – | – | 0.04% | 160 |
|
|
2019
Q2 | $128K | Hold |
5,010
| – | – | 0.05% | 160 |
|
|
2019
Q1 | $131K | Buy |
5,010
+2,800
| +127% | +$73.2K | 0.05% | 158 |
|
|
2018
Q4 | $51K | Buy |
+2,210
| New | +$51K | 0.02% | 215 |
|